Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Minoxidil works better when applied on a damp scalp than a dry one.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Dermoscopy helps diagnose different scalp conditions by showing unique signs for each disorder.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Minoxidil helps hair growth by activating enzymes in hair follicles.

Oral contraceptives may cause hair loss in women.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Higher androgen receptor levels in bald areas may cause hair loss, while estrogen receptors have less impact.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Exosomes may improve skin and hair treatments but need more research for safe use.

Spironolactone may help reduce hair loss in androgenic alopecia.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Compression therapy improved ankle movement, reduced leg swelling, and lessened pain in patients with venous leg ulcers.

PCOS often causes skin issues like excess hair, acne, hair thinning, and dark patches due to hormone imbalances and insulin resistance.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Trichoscopy helps tell apart Lichen planopilaris and Frontal fibrosing alopecia from other hair loss conditions.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Minoxidil helps hair regrowth and has anti-aging effects on hair follicles.

Caffeine in Alpecin shampoo may help prolong hair root activity and reduce hair loss.

Minoxidil rejuvenates hair follicles and reduces aging signs in male pattern baldness.